# AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure

> **NCT01484951** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 74 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Brinzolamide 1% and timolol 0.5% fixed combination eye drops

## Key facts

- **NCT ID:** NCT01484951
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2013-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01484951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01484951, "AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01484951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*